Immunology of leishmaniasis
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 4 (4) , 413-418
- https://doi.org/10.1016/s0952-7915(06)80032-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interleukin-4 Inhibits Human Macrophage Activation by Tumor Necrosis Factor, Granulocyte-Monocyte Colony-Stimulating Factor, and Interleukin-3 for Antileishmanial Activity and Oxidative Burst CapacityThe Journal of Infectious Diseases, 1992
- Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophagesResearch in Immunology, 1991
- Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophagesEuropean Journal of Immunology, 1991
- Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane.The Journal of Experimental Medicine, 1991
- The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages.The Journal of Experimental Medicine, 1991
- Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor‐α production by macrophages is induced by the synergistic action of interferon (IFN)‐γ and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN‐γ and IL 4European Journal of Immunology, 1991
- Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cellsInternational Immunology, 1991
- Exacerbation of experimental murine cutaneous leishmaniasis with CD4+Leishmania major‐specific T cell lines or clones which secrete interferon‐γ and mediate parasite‐specific delayed‐type hypersensitivityEuropean Journal of Immunology, 1991
- Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon‐γ to activate murine macrophages for killing of Leishmania major amastigotesEuropean Journal of Immunology, 1991
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990